These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 1870213)

  • 1. Cytopathic variants of an attenuated isolate of human immunodeficiency virus type 2 exhibit increased affinity for CD4.
    Hoxie JA; Brass LF; Pletcher CH; Haggarty BS; Hahn BH
    J Virol; 1991 Sep; 65(9):5096-101. PubMed ID: 1870213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human immunodeficiency virus type 2 envelope glycoprotein: differential CD4 interactions of soluble gp120 versus the assembled envelope complex.
    Mulligan MJ; Ritter GD; Chaikin MA; Yamshchikov GV; Kumar P; Hahn BH; Sweet RW; Compans RW
    Virology; 1992 Mar; 187(1):233-41. PubMed ID: 1736526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant CD4-selected human immunodeficiency virus type 1 variants with reduced gp120 affinity for CD4 and increased cell fusion capacity.
    McKeating J; Balfe P; Clapham P; Weiss RA
    J Virol; 1991 Sep; 65(9):4777-85. PubMed ID: 1870202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular characterization of an attenuated human immunodeficiency virus type 2 isolate.
    Kumar P; Hui HX; Kappes JC; Haggarty BS; Hoxie JA; Arya SK; Shaw GM; Hahn BH
    J Virol; 1990 Feb; 64(2):890-901. PubMed ID: 2296086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The env protein of an infectious noncytopathic HIV-2 is deficient in syncytium formation.
    Mulligan MJ; Kumar P; Hui HX; Owens RJ; Ritter GD; Hahn BH; Compans RW
    AIDS Res Hum Retroviruses; 1990 Jun; 6(6):707-20. PubMed ID: 2364016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological characterization of a simian immunodeficiency virus-like retrovirus (HTLV-IV): evidence for CD4-associated molecules required for infection.
    Hoxie JA; Haggarty BS; Bonser SE; Rackowski JL; Shan H; Kanki PJ
    J Virol; 1988 Aug; 62(8):2557-68. PubMed ID: 2839686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-1 R5 Macrophage-Tropic Envelope Glycoprotein Trimers Bind CD4 with High Affinity, while the CD4 Binding Site on Non-macrophage-tropic, T-Tropic R5 Envelopes Is Occluded.
    Quitadamo B; Peters PJ; Repik A; O'Connell O; Mou Z; Koch M; Somasundaran M; Brody R; Luzuriaga K; Wallace A; Wang S; Lu S; McCauley S; Luban J; Duenas-Decamp M; Gonzalez-Perez MP; Clapham PR
    J Virol; 2018 Jan; 92(2):. PubMed ID: 29118121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Several CD4 domains can play a role in human immunodeficiency virus infection in cells.
    Poulin L; Evans LA; Tang SB; Barboza A; Legg H; Littman DR; Levy JA
    J Virol; 1991 Sep; 65(9):4893-901. PubMed ID: 1714523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Receptor interference mediated by the envelope glycoproteins of various HIV-1 and HIV-2 isolates.
    Martin RA; Nayak DP
    Virus Res; 1996 Dec; 45(2):135-45. PubMed ID: 8896248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Envelope glycoproteins from human immunodeficiency virus types 1 and 2 and simian immunodeficiency virus can use human CCR5 as a coreceptor for viral entry and make direct CD4-dependent interactions with this chemokine receptor.
    Hill CM; Deng H; Unutmaz D; Kewalramani VN; Bastiani L; Gorny MK; Zolla-Pazner S; Littman DR
    J Virol; 1997 Sep; 71(9):6296-304. PubMed ID: 9261346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistance of primary isolates of human immunodeficiency virus type 1 to neutralization by soluble CD4 is not due to lower affinity with the viral envelope glycoprotein gp120.
    Turner S; Tizard R; DeMarinis J; Pepinsky RB; Zullo J; Schooley R; Fisher R
    Proc Natl Acad Sci U S A; 1992 Feb; 89(4):1335-9. PubMed ID: 1741386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD4-independent infection of two CD4(-)/CCR5(-)/CXCR4(+) pre-T-cell lines by human and simian immunodeficiency viruses.
    Borsetti A; Parolin C; Ridolfi B; Sernicola L; Geraci A; Ensoli B; Titti F
    J Virol; 2000 Jul; 74(14):6689-94. PubMed ID: 10864687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential susceptibility of naive and memory CD4+ T cells to the cytopathic effects of infection with human immunodeficiency virus type 1 strain LAI.
    Chun TW; Chadwick K; Margolick J; Siliciano RF
    J Virol; 1997 Jun; 71(6):4436-44. PubMed ID: 9151834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attenuation of human immunodeficiency virus type 1 cytopathic effect by a mutation affecting the transmembrane envelope glycoprotein.
    Kowalski M; Bergeron L; Dorfman T; Haseltine W; Sodroski J
    J Virol; 1991 Jan; 65(1):281-91. PubMed ID: 1702159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conformational changes induced in the envelope glycoproteins of the human and simian immunodeficiency viruses by soluble receptor binding.
    Sattentau QJ; Moore JP; Vignaux F; Traincard F; Poignard P
    J Virol; 1993 Dec; 67(12):7383-93. PubMed ID: 7693970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytolysis by CCR5-using human immunodeficiency virus type 1 envelope glycoproteins is dependent on membrane fusion and can be inhibited by high levels of CD4 expression.
    LaBonte JA; Madani N; Sodroski J
    J Virol; 2003 Jun; 77(12):6645-59. PubMed ID: 12767984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyanovirin-N binds to gp120 to interfere with CD4-dependent human immunodeficiency virus type 1 virion binding, fusion, and infectivity but does not affect the CD4 binding site on gp120 or soluble CD4-induced conformational changes in gp120.
    Esser MT; Mori T; Mondor I; Sattentau QJ; Dey B; Berger EA; Boyd MR; Lifson JD
    J Virol; 1999 May; 73(5):4360-71. PubMed ID: 10196334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human immunodeficiency virus type 2 infection and fusion of CD4-negative human cell lines: induction and enhancement by soluble CD4.
    Clapham PR; McKnight A; Weiss RA
    J Virol; 1992 Jun; 66(6):3531-7. PubMed ID: 1583722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction by human immunodeficiency viruses types 1 and 2 of degradation of CD4 but not of a CD4 mutant unable to bind viral envelope glycoproteins.
    Cucchiarini M; Cagnon L; Giordanengo V; Doglio A; Lefebvre JC
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Apr; 8(5):427-36. PubMed ID: 7697438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD4-independent utilization of the CXCR4 chemokine receptor by HIV-1 and HIV-2.
    Hoxie JA; LaBranche CC; Endres MJ; Turner JD; Berson JF; Doms RW; Matthews TJ
    J Reprod Immunol; 1998 Dec; 41(1-2):197-211. PubMed ID: 10213311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.